It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ICUI’s FA Score shows that 1 FA rating(s) are green whileVMD’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ICUI’s TA Score shows that 4 TA indicator(s) are bullish while VMD’s TA Score has 4 bullish TA indicator(s).
ICUI (@Pharmaceuticals: Other) experienced а -11.42% price change this week, while VMD (@Medical/Nursing Services) price change was +19.73% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.28%. For the same industry, the average monthly price growth was -2.96%, and the average quarterly price growth was +3.30%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.73%. For the same industry, the average monthly price growth was +0.69%, and the average quarterly price growth was +3.98%.
ICUI is expected to report earnings on Nov 10, 2025.
VMD is expected to report earnings on Nov 04, 2025.
Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Medical/Nursing Services (-1.73% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
ICUI | VMD | ICUI / VMD | |
Capitalization | 2.79B | 275M | 1,013% |
EBITDA | 279M | 44.2M | 631% |
Gain YTD | -27.273 | -11.471 | 238% |
P/E Ratio | N/A | 20.88 | - |
Revenue | 2.42B | 233M | 1,039% |
Total Cash | 290M | 10.2M | 2,843% |
Total Debt | 1.6B | 6.76M | 23,669% |
ICUI | VMD | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 26 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 93 Overvalued | 63 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 92 | 70 | |
PRICE GROWTH RATING 1..100 | 87 | 57 | |
P/E GROWTH RATING 1..100 | 2 | 88 | |
SEASONALITY SCORE 1..100 | 75 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
VMD's Valuation (63) in the null industry is in the same range as ICUI (93) in the Medical Specialties industry. This means that VMD’s stock grew similarly to ICUI’s over the last 12 months.
VMD's Profit vs Risk Rating (100) in the null industry is in the same range as ICUI (100) in the Medical Specialties industry. This means that VMD’s stock grew similarly to ICUI’s over the last 12 months.
VMD's SMR Rating (70) in the null industry is in the same range as ICUI (92) in the Medical Specialties industry. This means that VMD’s stock grew similarly to ICUI’s over the last 12 months.
VMD's Price Growth Rating (57) in the null industry is in the same range as ICUI (87) in the Medical Specialties industry. This means that VMD’s stock grew similarly to ICUI’s over the last 12 months.
ICUI's P/E Growth Rating (2) in the Medical Specialties industry is significantly better than the same rating for VMD (88) in the null industry. This means that ICUI’s stock grew significantly faster than VMD’s over the last 12 months.
ICUI | VMD | |
---|---|---|
RSI ODDS (%) | 4 days ago72% | 4 days ago85% |
Stochastic ODDS (%) | 4 days ago76% | 4 days ago75% |
Momentum ODDS (%) | 4 days ago74% | 4 days ago73% |
MACD ODDS (%) | 4 days ago76% | 4 days ago71% |
TrendWeek ODDS (%) | 4 days ago68% | 4 days ago75% |
TrendMonth ODDS (%) | 4 days ago68% | 4 days ago79% |
Advances ODDS (%) | 18 days ago66% | 4 days ago74% |
Declines ODDS (%) | 6 days ago69% | 11 days ago77% |
BollingerBands ODDS (%) | 4 days ago69% | 4 days ago83% |
Aroon ODDS (%) | N/A | 4 days ago83% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
CVTRX | 53.26 | 0.30 | +0.57% |
Calamos Growth & Income A | |||
GESOX | 19.16 | 0.07 | +0.37% |
Lazard Global Equity Select Port Open | |||
ESCQX | 10.85 | 0.03 | +0.28% |
Embark Small Cap Equity Retirement | |||
CBFAX | 40.16 | 0.08 | +0.20% |
American Funds Global Balanced 529A | |||
APSDX | 16.62 | -0.07 | -0.42% |
NYLI Fiera SMID Growth Class R6 |
A.I.dvisor indicates that over the last year, ICUI has been loosely correlated with CLPT. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if ICUI jumps, then CLPT could also see price increases.
Ticker / NAME | Correlation To ICUI | 1D Price Change % | ||
---|---|---|---|---|
ICUI | 100% | -13.13% | ||
CLPT - ICUI | 57% Loosely correlated | +0.28% | ||
NVST - ICUI | 52% Loosely correlated | +0.75% | ||
A - ICUI | 49% Loosely correlated | +0.56% | ||
DHR - ICUI | 46% Loosely correlated | +1.04% | ||
VCYT - ICUI | 45% Loosely correlated | -1.12% | ||
More |
A.I.dvisor indicates that over the last year, VMD has been loosely correlated with ENOV. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if VMD jumps, then ENOV could also see price increases.
Ticker / NAME | Correlation To VMD | 1D Price Change % | ||
---|---|---|---|---|
VMD | 100% | +2.01% | ||
ENOV - VMD | 44% Loosely correlated | -0.28% | ||
AXGN - VMD | 42% Loosely correlated | -1.21% | ||
MYO - VMD | 37% Loosely correlated | +2.23% | ||
RDNT - VMD | 35% Loosely correlated | +1.58% | ||
ICUI - VMD | 34% Loosely correlated | -13.13% | ||
More |